Evaluating the effectiveness of AI-enhanced "One Body, Two Wings" pharmacovigilance models in China: a nationwide survey on medication safety and risk management.

ABSTRACT:

Background

This study evaluates the effectiveness of AI-enhanced "One Body Two Wings" pharmacovigilance models in China, focusing on improving medication safety and risk management. As the pharmaceutical landscape grows more complex, integrating AI into pharmacovigilance offers the potential to enhance adverse drug reaction (ADR) detection and monitoring.

Methods

A nationwide cross-sectional survey was conducted from June 25 to August 10, 2024, involving 1,000 participants from pharmacovigilance centers, hospitals, corporations, and the general public. Participants were recruited through stratified convenience sampling to ensure a broad geographical and professional representation. Data were collected through a validated questionnaire and analyzed using ANOVA, regression ana

SUBMITTER: Yang J 

PROVIDER: S-EPMC12540474 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature